Eurofins-Cerep S.A.
PAR: ALECR.PA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Euronext Paris
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Damien Vielliard
- Employees
- 209
- Headquarters
- Vienne, France
- IPO year
- 2000
- Market cap
- €81.2M
- Website
- https://www.eurofins.fr/cerep
Loading ALECR…
Loading profile data…Frequently asked questions about ALECR
What does Eurofins-Cerep S.A. (ALECR.PA) do?
Eurofins Cerep SA provides various drug discovery services to pharmaceutical and biotechnology companies worldwide. The company's research services include compound management, high-throughput screening, in vitro safety profiling, lead optimization (or SAR) profiling, in vitro ADME profiling, and in vivo PK. It also offers assay design and devel...
Where does ALECR.PA trade?
Eurofins-Cerep S.A. (ALECR.PA) trades on the Euronext Paris.
What sector is ALECR.PA in?
Eurofins-Cerep S.A. (ALECR.PA) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Eurofins-Cerep S.A.?
Damien Vielliard is the chief executive officer of Eurofins-Cerep S.A. (ALECR.PA).
Where is Eurofins-Cerep S.A. headquartered?
Eurofins-Cerep S.A. is headquartered in France.
Does ALECR.PA pay a dividend?
Eurofins-Cerep S.A. (ALECR.PA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ALECR.PA go public?
Eurofins-Cerep S.A. (ALECR.PA) completed its initial public offering in 2000.